Purpose: InvDup(15) syndrome is one of the most common chromosomal abnormalities associated with epilepsy. Here we review the seizure types described in InvDup(15) patients and the main electroclinical, therapeutic, and prognostic aspects of the syndrome. Methods: A literature search of PubMed, MEDLINE, and EMBASE was performed to identify papers examining InvDup(15) syndrome and epilepsy. Results: About 65% of the InvDup(15) patients described in the literature had multiple seizure types with a predominance (40.4%) of tonic-clonic seizures. Age at seizure onset was before 10 years in more than half of them. Patients suffered from a variety of EEG abnormalities, generalized spike activity being the most frequent. Brain MRI was unremarkable in the majority of patients. Treatment was with several anticonvulsant drugs used as mono-or polytherapy. Valproic acid was the most common treatment against generalized seizures and was often effective, although drug resistance was a major concern in a large number of cases. Finally, more than 30% of the children suffered from infantile spasms, and status epilepticus was described in nearly 20% of patients, occasionally resulting in death. Conclusion: Seizures are very common in InvDup(15) patients, who suffer from a variety of seizure types. Information about EEG and brain MRI findings, seizure treatment, and prognosis is often poor. The overall prognosis is fair. Prospective studies of larger samples are needed, to gain further insights into the natural history of InvDup(15) syndrome.
Introduction
The proximal region of chromosome 15q is known for its instability, due to the presence of repeated DNA elements. Rearrangements include the deletions associated with Angelman syndrome (AS) and Prader-Willi syndrome (PWS), which are associated respectively with the maternal and paternal origin of the deletion [1, 2] . Inverted duplication of chromosome 15, or InvDup(15) , is the most common of the heterogeneous extra structurally abnormal chromosomes [3, 4] . It has been estimated that 50% of supernumerary marker chromosomes are derived from chromosome 15, and that InvDup (15) accounts for approximately 80% of them [5] . Its incidence at birth is estimated to be 1/30,000, with a sex ratio of almost 1 [6] . InvDup (15) can be divided into two main groups, depending on the absence or presence of the PWS/AS critical region, which involves different phenotypic consequences [7] [8] [9] [10] . In addition, most children with small InvDup(15)s have a normal phenotype, whereas large InvDup (15) s are usually associated with multiple abnormalities [3, 4, 11] . The maternal origin of the imprinted chromosome seems to affect the patient's phenotype [12] .
Muscle hypotonia is seen in nearly all patients and is frequently associated with joint hyperextensibility and drooling. Other physical findings are non-specific and include a wide range of minor dysmorphic facial features, like down-slanting palpebral fissures, epicanthic folds, low-set eyes and/or posteriorly rotated ears, highly arched palate, broad nose, anteverted nostrils; 5th finger clinodactyly and abnormal dermatoglyphics; partial 2nd and 3rd toe syndactyly, brachycephaly, frontal bossing, synophrys, [4, 18, 19] . Speech development delay with impairment of expressive language and comprehension is common. Autistic features, including eye gaze avoidance, impaired facial expression with limited sharing of enjoyment, interests, or achievements with others, and stereotyped motor mannerisms are also frequently described in these children [15, 19, 20] . Survival is not significantly reduced.
InvDup (15) diagnosis is by standard cytogenetics and FISH analysis. Molecular studies, such as parental DNA microsatellite analysis and methylation analysis of the proband's DNA, are also needed to establish the parent-of-origin of the syndrome [21, 22] .
Despite the growing interest in InvDup (15) syndrome, little attention has been paid to the characterization of the epilepsy features, EEG abnormalities, and long-term prognosis of these patients. This review provides a systematic update of recent research and of the clinical findings reported in the past 22 years.
Methods
The MEDLINE and EMBASE databases were searched using the terms "chromosome 15", "isodicentric chromosome 15 syndrome", "duplication-inversion 15q11", "inverted duplication 15", "invdup (15)", 'idic (15)", "non-distal tetrasomy 15q', 'epilepsy', "seizures", and "EEG". The last search was run in March 2017. Papers regarding other chromosome 15 abnormalities, those that did not describe the features of epilepsy, and those that were not in English were excluded, leaving 16 articles of which the earliest was published in 1994. Their full text was examined and their references were consulted for any additional relevant papers. The main seizure types experienced by these patients, age at syndrome onset, the EEG and brain MRI findings associated with InvDup(15), and seizure management, treatment efficacy, and prognosis data are described below.
Results
Of the 16 articles retrieved by the search, 12 were case reports and one was a survey, involving a total number of 144 patients with InvDup (15) Gender was reported only for 24 of the 98 patients with multiple seizure types, who were 13 females and 11 males.
The EEG features of InvDup(15) patients are seldom described in the medical literature, due to a lack of serial EEG studies [6] . In these 13 studies of 144 patients, 94 of whom had multiple seizure types, EEG findings were reported only for 24 patients. All interictal EEGs (Table 1) were abnormal and showed generalized spike activity (8 patients), generalized spike and wave complexes (11 patients), generalized polyspikes (4 patients), multifocal diffuse abnormalities (3 patients), epileptiform discharges in the left temporal lobe or parasagittal and midline regions (2 patients), and hypsarrhythmia, theta activity, bilateral fast rhythm during sleep, slow irregular waves in the left temporal-parietal region, and nonspecific abnormalities (1 case each). Ictal EEGs were recorded only in 3 patients, who showed respectively: (i) diffuse spikes followed by high-voltage spikes and waves in the right frontal-temporal region during an episode of head rotation to the right followed by rotation to the left, with tonic adduction of the arms, chewing movements, and loss of consciousness for 15 s; (ii) diffuse fast spikes followed by a voltage decrease; and (iii) mild diffuse attenuation of background activity with low-amplitude, rhythmic theta activity; a year later, another ictal EEG showed diffuse delta bursts followed by an electrodecremental response.
The brain MRI findings of InvDup (15) patients are reported in the literature for only 18 cases, of which 10 showed normal features. As regards the abnormal findings, Kobayashi et al. [23] described a 7-year-old boy with infantile spasms who had enlarged ventricles. Bingham et al. [24] described a patient with infantile spasms and enlarged subarachnoid spaces. Battaglia et al. [15] described a woman with atypical absences, axial tonic seizures mainly during sleep, and sudden atonic falls of the head; her brain MRI and CT findings were normal except for microcephaly and calvarial thickening. Buoni et al. [29] described 3 InvDup (15) patients with epilepsy and abnormal brain MRI findings: one showed thinning of the corpus callosum and increased signal density around the posterior horns of the lateral ventricles; another was a boy with myoclonic encephalopathy, whose brain MRI scans disclosed a moderate volume increase of the cerebrospinal fluid surrounding the left temporal pole; the third case was a girl who developed generalized clonic seizure at age 9 years and showed a moderate increase in pericerebral spaces on MRI. Maggoutta et al. [27] reported the case of a boy with generalized seizures associated with thinning of the corpus callosum and delayed myelination of the cerebral hemispheres. Finally, Jon Soo Kim et al. [28] described a 10-month baby girl with generalized tonic-clonic seizures and mild brain atrophy on MRI. Therapeutic management was discussed in all papers except the one by Dennis et al. [30] . In the other 12 case reports and in the survey by Conant et al. [31] , involving 76 children with InvDup (15) and epilepsy, the anticonvulsant drugs used most commonly were valproic acid (63.15%), carbamazepine (32.9%), lamotrigine and topiramate (31.58% each), and levetiracetam (30.26%). ACTH was administered to 15 patients with infantile spasms, of whom 11 (73.33%) experienced spasm reduction or total remission [11, 23, 24, 31] . Benzodiazepines such as clonazepam (21.05%), clobazam (13.15%), and lorazepam (7.9%) achieved poor seizure control in most cases, but were relatively effective when combined with antiepileptic drugs [4, 11, 15, 29, 31] . Carbamazepine and oxcarbazepine used as monotherapy ensured seizure control in only 2 patients [1, 29] . Other medications included zonisamide (15.79%), vigabatrin (14.47%), phenytoin (13.15%), oxcarbazepine and gabapentin (9.2% each), and phenobarbital and rufinamide (7.9% each). Total seizure control by these drugs was reported in 10.52% of cases: in a patient described by Battaglia et al. [15] , tonic, atonic, and GTC seizures were refractory to carbamazepine, valproic acid, phenobarbital, and clonazepam and eventually responded to a combination of phenobarbital and phenytoin when the patient was 16 years old; however, seizure onset at age 8 years involved that by then he had lost language completely. Total seizure control was achieved in 4 patients described by Buoni et al. [29] : with valproic acid in a boy with atypical absences and myoclonic atonic seizures; with clonazepam and sodium valproate in a patient with myoclonic jerks and tonic spasms; with carbamazepine in a patient with generalized clonic seizures; and with gabapentin combined with carbamazepine and phenobarbital in a girl with GTC seizures refractory to different anticonvulsant drug (AED) monotherapies. Valente et al. [11] reported complete control of total seizures in 3 of 5 patients: a boy with infantile spasms who responded to a combination of valproic acid and vigabatrinin; a girl with generalized tonic-clonic seizures who responded to valproic acid and lamotrigine; and a patient with generalized tonic-clonic seizures who responded to oxcarbazepine monotherapy. Adverse effects including sedation, liver toxicity, anorexia, irritability, rash, fever, vomiting, loss of coordination, and cognitive slowing were reported by Conant et al. [31] .
Discussion
Patients with epilepsy show a significantly increased burden of chromosomal rearrangements, particularly when the disease is associated with mental retardation and neuropsychiatric features [32] . Epilepsy is common in patients with 15q13.3 microdeletion, which is found in about 1% of patients with idiopathic generalized epilepsy [33] . InvDup (15) is the most common heterogeneous extra structurally abnormal chromosome. InvDup (15) with presence of the PWS/AS critical region is associated with phenotypic abnormalities, mental retardation and, in more than 50% of cases, epilepsy. It has been suggested that epilepsy depends on the involvement of GABA receptors, since several genes, including those encoding GABA receptor subunits b3 and a5 are found in the duplicated region of chromosome 15 [34] . The SLC12A6 gene, which codes for a cation chloride cotransporter and is expressed in brain, heart, skeletal muscle and kidney, may also be involved in seizure pathogenesis [35] .
Little information is available with regard to the characterization of the epilepsy of these patients, EEG abnormalities, and longterm prognosis. Ninety-four (65.27%) of the 144 patients with InvDup(15) and epilepsy comprised in this review had multiple seizures types. The most common seizures were generalized tonicclonic (40.43%), whereas partial-onset, tonic, myoclonic, and atonic seizures and atypical absences all showed a similar frequency (from 24.74% to 29.79%). Data analysis demonstrated that InvDup (15) is not associated with a single type of seizures, and that a single patient may experience different seizure types in the course of his/her lifetime. Although generalized tonic-clonic seizures showed a slight predominance, more than 30% of patients with seizures had a history of infantile spasms and nearly 20% had had episodes of status epilepticus. Developmental regression was described in more than half of patients. As regards age at seizure onset, it was 10 years in 50% of cases, without significant gender differences. EEG data were available for only 24 of the 96 patients multiple seizure types. EEG abnormalities usually appear with the onset of epilepsy. Accordingly, background activity was abnormal in most patients. Generalized paroxysm characterized by highamplitude spikes, polyspikes, and wave complexes were commonly reported. Sleep structure was also often affected. The regions involved by the onset of paroxysms, which were reported in some studies, were the right frontal-temporal region, left temporal region, and left temporal-parietal region. The brain MRI findings were described for 18 of the 94 patients with multiple seizure types, and were unremarkable in 10. The other eight patients showed non-specific abnormalities such as enlargement of the ventricles or subarachnoid spaces, microcephaly, mild brain atrophy, thinning of the corpus callosum, a moderate volume increase of the cerebrospinal fluid surrounding the left temporal pole, and delayed hemisphere myelination. Treatment efficacy was assessed in 13 papers, involving 76 children who received a variety of anticonvulsants and often required polytherapy. ACTH was administered to 15 patients with infantile spasms, most of whom experienced spasm reduction or total remission. Valproic acid (mono-and polytherapy) was the anticonvulsant drug used most commonly to treat generalized seizures and yielded variable responses. Carbamazepine monotherapy was the first-line drug to treat patients with focal epilepsy and was administered in association with other anticonvulsants in several other cases. Outcomes were variable, since some patients responded well to an AED whereas others were resistant.
Conclusion
Although InvDup(15) syndrome associated with epilepsy is a major disorder, limited information is available on the EEG and brain MRI findings of the patients described in the literature and on their therapeutic management and prognosis. This involves that the features of InvDup (15) syndrome cannot at present be established with precision. More comprehensive information is available for seizure types. However, since the syndrome does not appear to be associated with a distinctive type, and since patients may experience different seizure types during their lifetime, it is impossible to establish a correlation with any clinical manifestations. The examination of further patients with InvDup(15) and epilepsy is expected to clarify whether the syndrome is associated with specific electroclinical and brain MRI findings. Prospective studies of larger patient samples would also provide greater insights into its natural history. Accurate evaluation of therapeutic management and long-term prognosis is also needed. Finally, early diagnosis of InvDup(15) syndrome and the adoption of more effective antiepileptic treatment would result in improved seizure control and patient outcomes.
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